Severity
Moderate
FDA Drug recall · Reported August 11, 2021
Lack of sterility assurance
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy recalled Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only,… - a moderate-severity action.
Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only,… was recalled by BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy in August 11, 2021. Reason: Lack of sterility assurance. Check the official notice for the remedy. Verify recall #D-0702-2021 with the FDA Drug before acting.
The recall
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy issued this moderate-severity FDA Drug recall-Lack of sterility assurance.
Sourced from official FDA Drug enforcement records. Verify recall #D-0702-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0702-2021) was formally reported on August 11, 2021, with the manufacturer initiating the action on July 30, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy is listed as the recalling firm, operating out of Temple Terrace, FL. Federal records list the affected scope as 253 syringes.
The documented reason for this recall is: Lack of sterility assurance Distribution data in the federal record shows the product reached: FL. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
253 syringes
Related Recalls
6
5 from same agency
Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare Central Pharmacy, 7802 E. Telecom Parkway, Temple Terrace, FL 33837
Lack of sterility assurance
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0702-2021 |
| Date reported | August 11, 2021 |
| Date initiated | July 30, 2021 |
| Recalling firm | BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy |
| Firm location | Temple Terrace, FL |
| Affected scope | 253 syringes |
| Distribution | FL |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 11, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.